P. Keith

发表

Development and implementation of guidelines in allergic rhinitis – an ARIA‐GA2LEN paper

B. Yawn, W. Busse, H. Schünemann, 2010 .

Development and implementation of guidelines in allergic rhinitis – an ARIA-GA 2 LEN paper

Bateman, B. Yawn, W. Busse, 2010 .

Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 *

G. Viegi, A. Chuchalin, J. Li, 2008, Allergy.

World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines

Enrico Compalati, Jan Brozek, Kirsten Beyer, 2010, The World Allergy Organization Journal.

Probiotics in the management and prevention of atopy

R. E. Wiley, P. Keith, J. Bienenstock, 2002, Clinical reviews in allergy & immunology.

MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

Rosalind W. Picard, D. Ryan, A. Sheikh, 2018, Clinical and Translational Allergy.

The International/Canadian Hereditary Angioedema Guideline

P. Keith, J. Bernstein, H. Farkas, 2019, Allergy, Asthma & Clinical Immunology.

Canadian hereditary angioedema guideline

P. Keith, J. Bernstein, H. Farkas, 2014, Allergy, Asthma & Clinical Immunology.

2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema

P. Keith, J. Bernstein, R. Schellenberg, 2010, Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology.

Proceedings of the Canadian society of allergy and clinical immunology annual scientific meeting 2015

Young Woong Kim, William H. Yang, L. Liang, 2016, Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology.

Commentaries on ‘Addition of long‐acting beta‐agonists to inhaled corticosteroids for chronic asthma in children’

P. Keith, S. Lazarus, Mike Thomas, 2010 .

Food- and exercise-induced anaphylaxis: importance of history in diagnosis.

P. Keith, David N Perkins, 2002, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

The September epidemic of asthma exacerbations in children: A search for etiology

S. Johnston, P. Keith, M. Sears, 2004, Journal of Allergy and Clinical Immunology.

Allergic rhinitis

P. Keith, Harold Kim, P. Small, 2018, Allergy, Asthma & Clinical Immunology.

The Allergic Rhinitis – Clinical Investigator Collaborative (AR-CIC): nasal allergen challenge protocol optimization for studying AR pathophysiology and evaluating novel therapies

L. Boulet, M. Boulay, P. Keith, 2015, Allergy, Asthma & Clinical Immunology.

Efficacy of Desloratadine in Persistent Allergic Rhinitis – A GA2LEN Study

J. Bousquet, T. Zuberbier, C. Bachert, 2010, International Archives of Allergy and Immunology.

Fluticasone furoate nasal spray consistently and significantly improves both the nasal and ocular symptoms of seasonal allergic rhinitis: a review of the clinical data

P. Keith, G. Scadding, 2008 .

Nonallergic rhinitis with eosinophilia syndrome

P. Keith, A. Ellis, 2006, Current allergy and asthma reports.

Canadian trial of sublingual swallow immunotherapy for ragweed rhinoconjunctivitis.

P. Keith, J. Hébert, M. Gold, 2004, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

ANAPHYLACTIC AND ANAPHYLACTOID REACTIONS IN THE PERIOPERATIVE PERIOD

P. Keith, J. Dolovich, 1992, Immunology and Allergy Clinics of North America.

Hereditary angiodema: a current state-of-the-art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema.

William H. Yang, P. Keith, R. Schellenberg, 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Ultrashort-specific immunotherapy successfully treats seasonal allergic rhinoconjunctivitis to grass pollen.

P. Keith, W. Aberer, F. Horak, 2011, Allergy and asthma proceedings.

Development and implementation of guidelines in allergic rhinitis – an ARIA-GA2LEN paper.

B. Yawn, W. Busse, H. Schünemann, 2010, Allergy.

Comparative responses to nasal allergen challenge in allergic rhinitic subjects with or without asthma

L. Boulet, M. Boulay, J. Denburg, 2011, Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology.

The effect of desloratadine on eosinophil/basophil progenitors and other inflammatory markers in seasonal allergic rhinitis: a placebo-controlled randomized study.

J. Denburg, P. Keith, A. Baatjes, 2005, International archives of allergy and immunology.

Systemic aspects of chronic rhinosinusitis.

J. Denburg, P. Keith, 2004, Immunology and allergy clinics of North America.

Effects of Continuous Plasma-Derived Subcutaneous C1-Esterase Inhibitor on Coagulation and Fibrinolytic Parameters

P. Keith, T. Machnig, T. Craig, 2020, Thrombosis and Haemostasis.

Repeatability and validity of cell and fluid‐phase measurements in nasal fluid: a comparison of two methods of nasal lavage

P. Keith, F. Hargreave, K. Parameswaran, 2001, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Eosinophil progenitors in airway diseases: clinical implications.

J. Denburg, P. Keith, 2008, Chest.

A cost-benefit analysis using a willingness-to-pay questionnaire of intranasal budesonide for seasonal allergic rhinitis

P. Keith, S. Birch, J. Haddon, 2000 .

Efficacy and tolerability of fluticasone propionate nasal drops 400 μg once daily compared with placebo for the treatment of bilateral polyposis in adults

P. Keith, J. Nieminen, J. Dolovich, 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.

P. Dorinsky, L. Boulet, P. Keith, 2007, Clinical therapeutics.

The Effect of Desloratadine on Eosinophil/Basophil Progenitors and Other Inflammatory Markers in Seasonal Allergic Rhinitis: A Placebo-Controlled Randomized Study

J. Denburg, P. Keith, A. Baatjes, 2005, International Archives of Allergy and Immunology.

Nonallergic rhinitis with eosinophilia syndrome and related disorders.

P. Keith, A. Ellis, 2007, Clinical allergy and immunology.

Clinical history as a predictor of penicillin skin test outcome.

P. Keith, S. Waserman, B. Wong, 2006, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Fluticasone furoate nasal spray reduces symptoms of uncomplicated acute rhinosinusitis: a randomised placebo-controlled study.

W. Fokkens, P. Keith, O. Pfaar, 2012, Primary care respiratory journal : journal of the General Practice Airways Group.

Population pharmacokinetics of subcutaneous C1‐inhibitor for prevention of attacks in patients with hereditary angioedema

P. Keith, J. Bernstein, W. Lumry, 2018, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Effectiveness of desloratadine 5 mg once daily in patients with symptoms of seasonal allergic rhinitis: results of a Canadian multicenter, open-label trial.

P. Keith, G. Luciuk, 2007, Clinical therapeutics.

Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs.

Todor A Popov, D. Postma, A. Sheikh, 2012, The Journal of allergy and clinical immunology.

Canadian clinical practice guidelines for acute and chronic rhinosinusitis.

J. Bouchard, P. Keith, M. Desrosiers, 2011, Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale.

Canadian clinical practice guidelines for acute and chronic rhinosinusitis

Peter Small, J. Bouchard, P. Keith, 2011, Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology.

Fluticasone furoate nasal spray consistently and significantly improves both the nasal and ocular symptoms of seasonal allergic rhinitis: a review of the clinical data.

P. Keith, G. Scadding, 2008, Expert opinion on pharmacotherapy.

Is diet partly responsible for differences in COVID-19 death rates between and within countries?

Ana C. Coelho, Todor A Popov, I. Pavord, 2020, Clinical and Translational Allergy.

Transitioning subcutaneous immunoglobulin 20% therapies in patients with primary and secondary immunodeficiencies: Canadian real-world study

P. Keith, Harold Kim, A. Gladiator, 2022, Allergy, Asthma & Clinical Immunology.

Passive transfer of peanut hypersensitivity by fresh frozen plasma.

P. Keith, M. Blajchman, D. Arnold, 2007, Archives of internal medicine.

MACVIA‐ARIA Sentinel NetworK for allergic rhinitis (MASK‐rhinitis): the new generation guideline implementation

F. Rodenas, G. Joos, R. Bourret, 2015, Allergy.

Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

A. Sheikh, O. Mayora, T. To, 2019, Clinical and Translational Allergy.

Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology.

A. Sheikh, O. Mayora, T. To, 2019, The Journal of allergy and clinical immunology.

ARIA 2016 executive summary: Integrated care pathways for predictive, preventive and personalized medicine across the life cycle

L. Boulet, J. Brożek, W. Fokkens, 2018 .

ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle

Todor A Popov, D. Postma, A. Sheikh, 2016, Clinical and Translational Allergy.

Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)

D. Postma, I. Pavord, A. Sheikh, 2016, Clinical and Translational Allergy.

Assessment of specific immunotherapy efficacy using a novel placebo score-based method.

P. Keith, W. Aberer, A. Frew, 2012, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Efficacy of desloratadine in intermittent allergic rhinitis: a GA2LEN study

J. Bousquet, T. Zuberbier, C. Bachert, 2009, Allergy.

World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines

Enrico Compalati, Jan Brozek, Kirsten Beyer, 2010, The World Allergy Organization journal.

Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema.

William H. Yang, P. Keith, P. Schmid‐Grendelmeier, 2010, The New England journal of medicine.

Current Status of Implementation of Self-Administration Training in Various Regions of Europe, Canada and the USA in the Management of Hereditary Angioedema

P. Keith, T. Craig, S. Neri, 2013, International Archives of Allergy and Immunology.

Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor

William H. Yang, P. Keith, P. Kralickova, 2017, The New England journal of medicine.

Development of the Hereditary Angioedema Rapid Triage (HAE-RT) Tool.

William H. Yang, P. Keith, M. Kastner, 2019, The journal of allergy and clinical immunology. In practice.

Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study

P. Keith, T. Machnig, J. Bernstein, 2021, Orphanet Journal of Rare Diseases.

Abstracts from the 10th C1-inhibitor deficiency workshop

William H. Yang, A. Szilágyi, M. Margaglione, 2017, Allergy, Asthma & Clinical Immunology.

Long-Term Outcomes with Subcutaneous C1-Inhibitor Replacement Therapy for Prevention of Hereditary Angioedema Attacks.

William H. Yang, P. Keith, J. Bernstein, 2019, The journal of allergy and clinical immunology. In practice.

P. Keith, T. Machnig, J. Bernstein, 2018, The journal of allergy and clinical immunology. In practice.

Prophylactic use of an anti-activated factor XII monoclonal antibody, garadacimab, for patients with C1-esterase inhibitor-deficient hereditary angioedema: a randomised, double-blind, placebo-controlled, phase 2 trial

William H. Yang, P. Keith, W. Lumry, 2022, The Lancet.

Co-occurrence between C1 esterase inhibitor deficiency and autoimmune disease: a systematic literature review

P. Keith, G. Krishnarajah, T. Craig, 2020, Allergy, Asthma & Clinical Immunology.

Correction to: Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study

P. Keith, T. Machnig, J. Bernstein, 2021, Orphanet Journal of Rare Diseases.

Nrf2-interacting nutrients and COVID-19: time for research to develop adaptation strategies

Ana C. Coelho, Todor A Popov, I. Pavord, 2020, Clinical and Translational Allergy.

Effect of intranasal corticosteroid treatment on allergen‐induced changes in group 2 innate lymphoid cells in allergic rhinitis with mild asthma

P. O'Byrne, P. Keith, R. Sehmi, 2021, Allergy. European Journal of Allergy and Clinical Immunology.

Rhinitis : A practical and comprehensive approach to assessment and therapy

J. Bouchard, J. Denburg, P. Keith, 2007 .

Nasal polyps: effects of seasonal allergen exposure.

P. Keith, J. Dolovich, D. Pengelly, 1994, The Journal of allergy and clinical immunology.

Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries?

Ana C. Coelho, Todor A Popov, I. Pavord, 2020, Clinical and Translational Allergy.

Montelukast as add-on therapy with inhaled corticosteroids alone or inhaled corticosteroids and long-acting beta-2-agonists in the management of patients diagnosed with asthma and concurrent allergic rhinitis (the RADAR trial).

J. Bouchard, P. Keith, J. Sampalis, 2009, Canadian respiratory journal.

Canadian Society of Allergy and Clinical Immunology annual scientific meeting 2016

Young Woong Kim, H. Pasterkamp, T. Schuster, 2017, Allergy, Asthma & Clinical Immunology.

Presence of positive skin prick tests to inhalant allergens and markers of T2 inflammation in subjects with chronic spontaneous urticaria (CSU): a systematic literature review

P. Keith, M. Wong, 2020, Allergy, Asthma & Clinical Immunology.

The burden of allergic rhinitis (AR) in Canada: perspectives of physicians and patients

P. Keith, R. Schellenberg, M. Desrosiers, 2012, Allergy, Asthma & Clinical Immunology.

Are intranasal corticosteroids all equally consistent in managing ocular symptoms of seasonal allergic rhinitis?

P. Keith, G. Scadding, 2009, Current medical research and opinion.

Fluticasone furoate nasal spray is the only intranasal corticosteroid to reduce the ocular symptoms of seasonal allergic rhinitis consistently.

P. Keith, Laurie A. Lee, 2011, The Journal of allergy and clinical immunology.

Ocular symptom efficacy and intranasal corticosteroids.

P. Keith, Laurie A. Lee, William T. Toler, 2009, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Comparison of budesonide Turbuhaler with budesonide aqua in the treatment of seasonal allergic rhinitis. Rhinocort Study Group.

P. Keith, W. Yang, M. Drouin, 1998, Canadian respiratory journal.

Canadian multidisciplinary expert consensus on the use of biologics in upper airways: a Delphi study

P. Keith, C. Lemière, B. Rotenberg, 2023, Journal of Otolaryngology - Head & Neck Surgery.

Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)

D. Postma, I. Pavord, A. Sheikh, 2017, Clinical and Translational Allergy.

Ultrashort-specific immunotherapy successfully treats seasonal allergic rhinoconjunctivitis to grass pollen.

P. Keith, W. Aberer, F. Horak, 2011, Allergy and asthma proceedings.

MP-AzeFlu in Moderate-to-Severe Allergic Rhinitis: A Literature Review

J. Bousquet, P. Keith, G. Scadding, 2021, International Archives of Allergy and Immunology.

A multicenter chart review of patient characteristics, treatment, and outcomes in hereditary angioedema: unmet need for more effective long-term prophylaxis

P. Keith, P. Busse, L. Diwakar, 2023, Allergy, Asthma & Clinical Immunology.

Significant Reduction In Combined Symptom And Medication Score Compared With Placebo With A Ragweed uSCIT Formulation For Seasonal Pollen Allergy

T. Casale, P. Keith, H. Kaiser, 2009 .

World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines

S. Vieths, H. Schünemann, J. Brożek, 2010, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

Protein expression of SARS-CoV-2 receptors ACE2 and TMPRSS2 in allergic airways after allergen challenge.

P. O'Byrne, P. Keith, M. Duong, 2023, Allergy. European Journal of Allergy and Clinical Immunology.

Canadian clinical practice guidelines for acute and chronic rhinosinusitis

J. Bouchard, P. Keith, R. Schellenberg, 2011, Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology.

ALLERGY, ASTHMA & CLINICAL IMMUNOLOGY REVIEW Open Access

P. Keith, J. Bernstein, R. Schellenberg, 2022 .

MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis.

Todor A Popov, I. Pavord, A. Sheikh, 2016, The Journal of allergy and clinical immunology.

Transitioning subcutaneous immunoglobulin 20% therapies in patients with primary and secondary immunodeficiencies: Canadian real-world study

P. Keith, Harold Kim, A. Gladiator, 2022, Allergy, Asthma & Clinical Immunology.

MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation.

Todor A Popov, D. Postma, R. Picard, 2015, Allergy.

Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

O. Mayora, T. To, D. Caillaud, 2019, Clinical and Translational Allergy.

Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs.

Todor A Popov, G. Koppelman, A. Boner, 2012, The Journal of allergy and clinical immunology.

Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema.

William H. Yang, P. Keith, P. Schmid‐Grendelmeier, 2010, The New England journal of medicine.

Eosinophil progenitors in airway diseases: clinical implications.

J. Denburg, P. Keith, 2008, Chest.

Allergic rhinitis

Glenis K Scadding, P. Keith, G. Scadding, 2018, Allergy, Asthma & Clinical Immunology.

Long-Term Outcomes with Subcutaneous C1-Inhibitor Replacement Therapy for Prevention of Hereditary Angioedema Attacks.

William H. Yang, P. Keith, J. Bernstein, 2019, The journal of allergy and clinical immunology. In practice.